Pharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study. [electronic resource]
Producer: 20171101Description: 850-856 p. digitalISSN:- 1365-2893
- Aged
- Aged, 80 and over
- Antiviral Agents -- administration & dosage
- Carbamates
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- administration & dosage
- Incidence
- Isoquinolines -- administration & dosage
- Male
- Middle Aged
- Pilot Projects
- Prospective Studies
- Pyrrolidines
- Renal Dialysis
- Renal Insufficiency -- complications
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.